Reduced myocardial perfusion reserve and transmural perfusion gradient in heart transplant arteriopathy assessed by magnetic resonance imaging

被引:89
作者
Muehling, OM
Wilke, NM
Panse, P
Jerosch-Herold, M
Wilson, BV
Wilson, RF
Miller, LW
机构
[1] Univ Minnesota, Sch Med, Dept Diagnost Radiol, Sect Cardiovasc MRI, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Sch Med, Dept Med, Div Cardiovasc, Minneapolis, MN 55455 USA
[3] Univ Florida, Dept Radiol, Jacksonville, FL USA
关键词
D O I
10.1016/S0735-1097(03)00924-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The goal of this study was to detect transplant arteriopathy (Tx-CHD) by a reduced myocardial perfusion reserve (MPR) and resting endomyocardial/epimyocardial perfusion ratio (Endo/Epi ratio). BACKGROUND Transplant arteriopathy often lacks clinical symptoms and is the reason for frequent surveillance angiography in heart transplant (Tx) recipients. Magnetic resonance perfusion imaging (MRPI) allows noninvasive assessment of transmural and selective endomyocardial and epimyocardial perfusion. METHODS Fifteen healthy volunteers (controls) and three groups (A, B, C) of Tx recipients were included. In controls and patients, MPR (hyperemic/resting perfusion) and Endo/Epi ratio were determined with MRPI after injection of gadolinium-diethylenetriamine pentaacetic acid at rest and during hyperemia (intravenous adenosine). Group A (n = 10) had no left ventricular (LV) hypertrophy and/or prior rejection, while patients in group B (n = 10) had at least one of these characteristics. Patients in group A and B had a normal coronary angiogram and a coronary flow reserve (CFR) of greater than or equal to2.5 (CFR = hyperemic/resting blood flow). Group C (n = 7) had Tx-CHD diagnosed by angiography and a reduced CFR (<2.5). RESULTS In group C, MPR (1.7 +/- 0.5) and Endo/Epi ratio (1.1 +/- 0.2) were significantly reduced compared with controls (4.2 +/- 0.7 and 1.6 +/- 0.3; both p < 0.0001), group A (3.6 +/- 0.7 and 1.6 +/- 0.2; both p < 0.0001) and B (2.7 +/- 0.9, p < 0.01 and 1.4 +/- 0.1, p < 0.04). Transplant arteriopathy can be excluded by an MPR of >2.3 with sensitivity and specificity of 100% and 85%. If LV hypertrophy and prior rejection are excluded, Tx-CHD can be excluded by an Endo/Epi ratio of >1.3 with 100% and 80%. CONCLUSIONS Magnetic resonance perfusion imaging detects Tx-CHD by a decreased MPR. After exclusion of LV hypertrophy and prior rejection, resting Endo/Epi ratio alone might be sufficient to indicate Tx-CHD. (C) 2003 by the American College of Cardiology Foundation.
引用
收藏
页码:1054 / 1060
页数:7
相关论文
共 24 条
[1]   Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance [J].
Al-Saadi, N ;
Nagel, E ;
Gross, M ;
Bornstedt, A ;
Schnackenburg, B ;
Klein, C ;
Klimek, W ;
Oswald, H ;
Fleck, E .
CIRCULATION, 2000, 101 (12) :1379-1383
[2]   SEROTONIN SELECTIVELY AGGRAVATES SUBENDOCARDIAL ISCHEMIA DISTAL TO A CORONARY-ARTERY STENOSIS DURING EXERCISE [J].
BACHE, RJ ;
STARK, RP ;
DUNCKER, DJ .
CIRCULATION, 1992, 86 (05) :1559-1565
[3]  
Billingham M E, 1990, J Heart Transplant, V9, P587
[4]   Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans [J].
Chareonthaitawee, P ;
Kaufmann, PA ;
Rimoldi, O ;
Camici, PG .
CARDIOVASCULAR RESEARCH, 2001, 50 (01) :151-161
[5]   REGIONAL TRANSIT-TIME ESTIMATION FROM IMAGE RESIDUE CURVES [J].
CLOUGH, AV ;
ALTINAWI, A ;
LINEHAN, JH ;
DAWSON, CA .
ANNALS OF BIOMEDICAL ENGINEERING, 1994, 22 (02) :128-143
[6]   ACCELERATED CORONARY VASCULAR-DISEASE IN THE HEART-TRANSPLANT PATIENT - CORONARY ARTERIOGRAPHIC FINDINGS [J].
GAO, SZ ;
ALDERMAN, EL ;
SCHROEDER, JS ;
SILVERMAN, JF ;
HUNT, SA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1988, 12 (02) :334-340
[7]   Magnetic resonance quantification of the myocardial perfusion reserve with a Fermi function model for constrained deconvolution [J].
Jerosch-Herold, M ;
Wilke, N ;
Stillman, AE ;
Wilson, RF .
MEDICAL PHYSICS, 1998, 25 (01) :73-84
[8]   Intravascular ultrasound imaging after cardiac transplantation: Advantage of multi-vessel imaging [J].
Kapadia, SR ;
Ziada, KM ;
L'Allier, PL ;
Crowe, TD ;
Rincon, G ;
Hobbs, RE ;
Bott-Silverman, C ;
Young, JB ;
Nissen, SE ;
Tuzcu, EM .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2000, 19 (02) :167-172
[9]   CORONARY BLOOD-FLOW IN MAN [J].
KLOCKE, FJ .
PROGRESS IN CARDIOVASCULAR DISEASES, 1976, 19 (02) :117-166
[10]   Effects of cardiac allograft vasculopathy on myocardial blood flow, vasodilatory capacity, and coronary vasomotion [J].
Kofoed, KF ;
Czernin, J ;
Johnson, J ;
Kobashigawa, J ;
Phelps, ME ;
Laks, H ;
Schelbert, HR .
CIRCULATION, 1997, 95 (03) :600-606